A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
2016 ◽
Vol 209
◽
pp. 310-316
◽
2019 ◽
Vol 73
(9)
◽
pp. 849
◽
2020 ◽
Vol 75
(11)
◽
pp. 971
Keyword(s):
Keyword(s):